MANNINO RAPHAEL J (Chief Scientific Officer) reported 2 transactions at MATINAS BIOPHARMA HOLDINGS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 6/24/2021ACC: 0000905718-21-000822
Officer· Chief Scientific Officer
Since Feb 2019
+27.99K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
28K acquired · 10.00 disposed
Non-Derivative Transactions2
Common Stock, par value $0.0001 per share
Direct
Shares
+8K
Price / share
—
Trade value
—
% of position
0.6%
6/19/2021
1.43M→1.44M
Common Stock, par value $0.0001 per share
Direct
Shares
+20K
Price / share
—
Trade value
—
% of position
1.4%
6/19/2021
1.44M→1.46M
Total
Net shares
+28K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share Direct | 6/19/2021 | J · J | +8K | — | — | 0.6% | 1.43M | 1.44M |
| Common Stock, par value $0.0001 per share Direct | 6/19/2021 | C · Conversion | +20K | — | — | 1.4% | 1.44M | 1.46M |
| Total | +28K | $0.00 | ||||||
Derivative Transactions1
Series B Preferred Stock
Direct
Converts to
Common Stock
20K shares
Shares
−10.00
Strike price
0.5
Held after
0.00
Exercisable
—
6/19/2021
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | Common Stock20K shares | 6/19/2021 | C · Conversion | −10.00 | 0.5 | — | 0.00 |